Client Login

Request Demo

Blog

New Clinical Research Highlights: Cancer Outcomes, Autoimmune Links, ILD Risk & PAH Medication Adherence

Walking May Reduce Mortality Risk in Breast Cancer Survivors With Genetic Obesity Risk Research published in JAMA Network Open found that women with breast cancer who have a higher genetic predisposition to obesity face a 15% greater mortality risk. However, adding approximately 15 minutes of walking per day may reduce that elevated risk to levels comparable to lower-risk patients. Study Explores Link Between Low-Risk HPV and Thyroid Eye Disease A research letter in JAMA Ophthalmology…
Read Full Article

Alabama Eyes ED Physician Staff-Level Transparency Requirement

The Alabama Senate is considering legislation that would require hospitals to publicly report emergency department physician coverage hours. Senate Bill 297 would mandate quarterly public reports detailing how many hours per week a physician is physically present in each hospital’s ED. The information would be posted online and displayed within the emergency department. The bill also authorizes the Alabama Department of Public Health to suspend or revoke licenses for noncompliance. If enacted, the requirement would…
Read Full Article

Alabama Lawmakers Advance Bill Allowing Insurer Reorganization

The Alabama Senate unanimously passed legislation Feb. 17 that would allow Blue Cross Blue Shield of Alabama to reorganize under a nonprofit holding company structure. The bill now moves to the Alabama House of Representatives and, if signed into law, would take effect Oct. 1. The proposal would permit BCBS Alabama’s board to authorize the restructuring without prior approval from the state insurance department. The new holding company could create subsidiaries and invest in other…
Read Full Article

3 Trends Shaping the GLP-1 Landscape

GLP-1 therapies continue to reshape chronic disease management, driving regulatory shifts, rapid market expansion and evolving clinical evidence. Here are three major trends to watch: Resource: 3 trends shaping the GLP-1 landscape

Alabama Among States Facing Growth in New Cancer Cases: 2026 Projections

Approximately 2.1 million new cancer cases are expected to be diagnosed nationwide in 2026, according to the American Cancer Society. Using 2022 state-level incidence data from the Centers for Disease Control and Prevention and 2026 projections from ACS, several states are expected to see significant increases in new diagnoses. Here’s a snapshot for Alabama: While some states are projected to see percentage increases of 20% or more, larger states such as Florida and Texas are…
Read Full Article

The 43 medications on TrumpRx: What to Know

TrumpRx.gov currently lists 43 brand-name medications available through manufacturer-run cash discount programs aimed primarily at uninsured patients or those without drug coverage. Here’s a quick breakdown: Providers and patients should review the full medication list and pricing details (linked below) to determine whether TrumpRx offers meaningful savings for specific therapies. Resource: The 43 medications on TrumpRx

Another Win for GLP-1s and Cancer Risk: 5 Key Study Notes

A study published February 10 in JAMA Network Open found that women with endometrial hyperplasia or benign uterine pathology who were treated with GLP-1 therapy plus progestins had a 66% lower risk of developing endometrial cancer compared to those treated with progestins alone. Researchers analyzed TriNetX data spanning 2005–2022 to evaluate cancer and hysterectomy outcomes across multiple treatment pathways. Here are five important takeaways: Providers should review the full study (linked below) to better understand…
Read Full Article

Drug Shortages Update: 12 Recent Discontinuations to Review

The FDA reports a notable decline in active drug shortages — from 194 in June to 80 as of February 12 — largely due to database updates, manufacturing recoveries, and reclassification of shortages. However, several recent discontinuities may still impact prescribing and inventory management. Below are 12 drugs recently listed in shortage or discontinued status: Because FDA shortage status can change frequently, providers are encouraged to review the official database and manufacturer communications (linked below)…
Read Full Article

Key CMS & Medicare Updates Providers Should Know

Several recent CMS and Medicare updates may impact laboratory operations, billing compliance, and coverage requirements. Below is a high-level overview of what’s changing and where providers should pay close attention. CLIA Program: Paper Fee Coupons & Certificates Ending March 1 Centers for Medicare & Medicaid Services is transitioning the CLIA program to fully electronic communications. After March 1, 2026, paper CLIA fee coupons and certificates will no longer be mailed, and payments must be made…
Read Full Article

Alabama Anesthesiologist Appointed to Leadership Role at UAB

Anesthesiologists’ continuous involvement throughout the perioperative process gives them a uniquely broad perspective on operating room efficiency and patient care — positioning many to step into leadership roles across health systems and ambulatory surgery centers. Among recent national leadership appointments reported by Becker’s, Matthew Sherrer, MD, an associate professor in the Department of Anesthesiology at UAB Health System, has been named assistant dean for faculty affairs. Dr. Sherrer’s appointment highlights Alabama’s continued representation in academic…
Read Full Article

Study Finds Many Patients Prefer Remote Consults for Ongoing Care

A recent study published in JAMA Network Open, and reported by The American Journal of Managed Care, found that more than half of patients with long-term conditions prefer remote consultations over in-person visits in certain scenarios. Overall, 37% of surveyed patients preferred remote care across multiple clinical situations, with synchronous methods (such as video or phone visits) favored over asynchronous messaging. Preference for remote care was highest when discussing test results (43%) and renewing medications…
Read Full Article

CVS Pharmacies Begin Accepting TrumpRx Discount Cards

CVS Health’s nearly 9,000 community pharmacies are now accepting TrumpRx discount cards as of Feb. 6, expanding access to savings on select medications for eligible patients. The discounts are determined by participating drug manufacturers, and patients can present a printed card at the pharmacy counter to receive applicable price reductions. In addition, CVS Specialty Pharmacy is participating in the TrumpRx Fertility program, offering reduced pricing on certain fertility medications. As discount programs and alternative pricing…
Read Full Article